OneBio
Overview
OneBio is a Cape Town-based early-stage investor and venture builder focused on the biotechnology sector. It operates both a traditional VC model and venture builder activities, partnering with biotech entrepreneurs by providing investment capital, expertise, networks, and support to build sustainable companies. The firm's investment focus includes African genomics, industrial biotech, the microbiome, future of food, and bioinformatics. It manages the "One Bio Seed investment fund".
Portfolio Companies
2
Website
onebio.africaInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| LifeQ | May 2021 | Series A | Co-investor |
| Aspyre Foods | May 2023 | Pre Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is OneBio based?
OneBio is headquartered in Cape Town, Western Cape, South Africa.
When was OneBio founded?
Founding year information for OneBio is not publicly available.
How many portfolio companies does OneBio have?
OneBio has 2 portfolio companies in Caplight's dataset.
What are some companies in OneBio's portfolio?
Portfolio companies visible on Caplight include LifeQ, Aspyre Foods.
What was OneBio's most recent investment shown here?
OneBio's most recent investment in this portfolio sample was in Aspyre Foods in 2023.
What sectors does OneBio focus on?
OneBio focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, AI, Data & Cloud Infrastructure.
What company stages does OneBio focus on?
OneBio typically invests at the Early stage.
What is OneBio's AUM?
OneBio's assets under management are estimated between $5.6M and $5.6M.